MAP1LC3B and colorectal cancer: In a study of ischemic stroke, MAP1LC3B was identified as a diagnostic marker for ischemic stroke and was highly expressed in the disease group, and MAP1LC3B was also found to be a potential biomarker for docosahexaenoic acid sensitivity in colorectal cancer cells (Chen et al., 2021).